Anishka D'souza

Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr et al. · Nature Medicine · 2023 · 133 citations · Full text

Medicine, Oncology, Urology +9

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study

Toni K. Choueiri, David F. McDermott, Jaime R. Merchan et al. · The Lancet Oncology · 2023 · 98 citations

Medicine, Oncology, Pharmacotherapy +10

Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial

Ana Oaknin, Claire F. Friedman, Lynda D. Roman et al. · Gynecologic Oncology · 2020 · 71 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in patients with muscle- invasive bladder cancer (MIBC): HCRN GU 16-257.

Matt D. Galsky, Siamak Daneshmand, Kevin Chan et al. · Journal of Clinical Oncology · 2021 · 40 citations

Medicine, Oncology, Surgery +15

Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial

Claire F. Friedman, Anishka D'souza, Diana Bello Roufai et al. · Gynecologic Oncology · 2024 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17